Europe Disposable Syringes Market Size, Share & Trends Analysis Report By Product (Conventional Syringes, Safety Syringes), By Application (Immunization Injections, Therapeutic Injections), By End-use, By Country, And Segment Forecasts, 2023 - 2032

The Europe disposable syringes market size was valued at USD 2,374.16 Billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.75% from 2023 to 2032.

Key Pointers

• The safety syringes led the market and Captured for more than 64.06% share of the Europe revenue in 2022.
• The hospitals led the market and Captured for more than 35.56% share of the Europe revenue in 2022.
• The other segment is anticipated to witness the fastest growth over the forecast period.
• The therapeutic injections led the market in terms of revenue in 2022.
• Germany dominated the market and Captured for over 16.30% share of Europe revenue in 2022.
• Denmark disposable syringes market is anticipated to witness the fastest growth over the forecast.

Report Scope of the Europe Disposable Syringes Market:

The growth of the Europe disposable syringes industry is attributed due to the increasing prevalence of chronic disorders,rising adoption of safety syringes, growing Hospital-Acquired Infections (HAIs), along with the growing number of surgeries in Europe.

Chronic diseases such as urological disorders, cancer, stroke, cardiovascular disorders, chronic renal disease, neurovascular diseases, and others are becoming more common. Non-communicable diseases (NCDs) account for 80% of the disease burden in EU countries and are the primary causes of preventable early deaths. As a result of high blood pressure, obesity, smoking, diabetes, a sedentary lifestyle, and excessive alcohol use, a large percentage of the population today is at risk of developing chronic diseases. For example, the European Chronic Disease Alliance (ECDA) 2021 report includes the following statistical data on the prevalence of certain conditions. Every year, cardiovascular disease (CVD) kills 3.9 million people in Europe and more than 1.8 million people in the EU.

While accounting for only one-eighth of the global population, Europe accounts for almost one-quarter of all cancer diagnoses, with approximately 3.7 million new patients each year. Lung, breast, stomach, liver, colon, and breast cancer are the leading causes of cancer fatalities each year. Moreover, one-fifth of all cancer-related deaths in the EU were caused by lung cancer. Additionally, the need for disposable syringes in various healthcare settings is likely to increase with the growing aging population, a demographic that is more susceptible to chronic illnesses such as diabetes and other lifestyle-related disorders. Due to these key factors, Europe's disposable syringes industry is anticipated to grow in near future.

Needle-stick injuries can happen when you use, disassemble, handle, or dispose of syringes and needles. Due to the high incidence rate of these injuries and their catastrophic consequences, healthcare personnel are encouraged to use syringes with a safety mechanism. This is increasing the need for disposable syringes. According to Eucomed, an organization that promotes the European medical technology industry, over one million needle-stick injuries occur in the region each year. An increase in demand for point-of-care administration and the continued rise of injectable medicines will further drive market growth.

Another driving factor is the need to control the spread of diseases such as HIV. The hazardous syringe disposal practice is one of the reasons for the high incidence rate of HIV. Safe injection procedures help prevent HIV contamination and transmission, which drives the industry. For example, the World Health Organization (WHO) estimated that in 2021, about 38.4 million individuals worldwide were infected with HIV. Similarly, roughly 107,000 people in the European Region were diagnosed with HIV in 2022, with approximately 17,000 in the EU/EEA region.

In addition, unsafe injections can cause abscesses, septicemia, nerve injury, and hemorrhagic fevers. One of the primary factors driving the growth of the safety syringes market is the rise in worries about needle-stick injuries to both patients and healthcare personnel. Sharps Technologies, Inc., for example, patented best-in-class, single-use smart safety syringe solutions in 2022 and announced the completion of its acquisition of Safeguard Medical's syringe production site in Hungary. These latest pharmacological advances are intended to promote safe injection techniques by reducing the possibility of contamination. Thus, increasing demand for disposable syringes in Europe.

Various organizations and market players are meeting the health needs of children and adults in Ukraine and in surrounding countries affected by Russia’s invasion of Ukraine. For instance, in February 2022, Americares supplied over 242 tons of pharmaceuticals and medical supplies worth over USD 48 Million to Ukrainian hospitals and emergency responders, and additional shipments are on the way. These shipments contain trauma kits, IV fluids, wound care supplies, antibiotics, and labor and delivery equipment.

Additionally, Americares awarded grants totaling more than USD 2 million to more than 40 groups in Poland, Romania, Slovakia, and Ukraine that promote health. Additionally, the Americares Medical Outreach program also provided more than USD 3.3 million in donated medicines and medical supplies to finance the travels of 20 volunteer medical teams to Poland, Ukraine, and Romania.

The increasing prevalence of chronic diseases and the rising geriatric population are among the major factors driving the market growth. For instance, as per Statistics Sweden (SCB), the proportion of people aged 80 and above is expected to increase by 50% by 2028.

Europe Disposable Syringes Market Segmentation: